Chappé Céline, Riffaud Laurent, Tréguier Catherine, Carsin-Nicol Béatrice, Veillard David, Chiforeanu Dan Cristian, Grill Jacques, Frappaz Didier, André Nicolas, Millot Fréderic, Vinchon Matthieu, Sirvent Nicolas, Edan Christine
Department of Pediatric Oncology, Pontchaillou University Hospital, Rennes, France.
Childs Nerv Syst. 2013 Apr;29(4):565-71. doi: 10.1007/s00381-012-2016-1. Epub 2013 Jan 10.
Gliomatosis cerebri (GC) is a rare neoplasm including a variety of tumors, with extremely variable evolution and heterogeneity of prognosis. It may appear either de novo or after a focal glioma, involve predominantly the white or the gray matter, and concern either pediatric or adult patients. We focused on primary GC involving exclusively gray matter in a pediatric population in order better to define the presentation and outcome of this disease.
We reviewed the databases of seven Departments of Pediatric Oncology to identify pediatric cases of GC between 1990 and 2007. Patients were included if they demonstrated a diffuse infiltrative process involving gray matter in magnetic resonance imaging (MRI) and histological tissue analyses, confirming a proliferative glial disorder.
Fourteen patients with a median age of 8 years were identified. Epilepsy was the main presenting symptom. Brain MRI showed a lesion of the temporal and insular cerebral cortex associated with tumoral infiltration of the thalami and the basal ganglia. Histological examination confirmed the diagnosis of high-grade glioma. Prognosis was always very gloomy in the short term, with a median survival of less than a year.
This rare entity, whose prognosis is appalling whatever the treatment proposed, should be clearly identified within the heterogeneous group of GC in the same way as diffuse intrinsic pontine gliomas have been identified among brain stem tumors. Systematic biopsies appear essential to permit the molecular studies which will assist in guiding the choice of future targeted treatments.
大脑胶质瘤病(GC)是一种罕见的肿瘤,包括多种肿瘤类型,其病程演变极为多样,预后存在异质性。它既可能原发出现,也可能继发于局灶性胶质瘤之后,主要累及白质或灰质,可发生于儿童或成人患者。我们聚焦于仅累及儿童人群灰质的原发性GC,以便更好地明确该疾病的表现及预后。
我们回顾了七个儿科肿瘤学部门的数据库,以确定1990年至2007年间的儿童GC病例。若患者在磁共振成像(MRI)及组织学分析中显示出累及灰质的弥漫性浸润过程,证实为增殖性胶质细胞疾病,则纳入研究。
共确定了14例患者,中位年龄为8岁。癫痫是主要的首发症状。脑部MRI显示颞叶和岛叶皮质有病变,伴有丘脑和基底节的肿瘤浸润。组织学检查确诊为高级别胶质瘤。短期内预后始终非常严峻,中位生存期不到一年。
这种罕见的疾病,无论采用何种治疗方法,其预后都令人震惊,应在GC的异质性组中明确识别,就如同在脑干肿瘤中识别弥漫性固有脑桥胶质瘤一样。系统性活检对于开展分子研究似乎至关重要,这些研究将有助于指导未来靶向治疗的选择。